Company Encyclopedia
View More
name
Milestone Scientific
MLSS.US
Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments. The company provides the Wand, a single use disposable handpiece device for dental procedures that require local anesthetic under the CompuDent and STA Single Tooth Anesthesia System names. It also offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances; and disposable injection handpiece for the tactile control during the injection.
1.407 T
MLSS.USMarket value -Rank by Market Cap -/-

Financial Score

05/12/2025 Update
D
Health Care EquipmentIndustry
Industry Ranking133/171
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreD
    • ROE-136.47%E
    • Profit Margin-74.66%E
    • Gross Margin69.52%A
  • Growth ScoreD
    • Revenue YoY0.59%C
    • Net Profit YoY-44.41%D
    • Total Assets YoY-24.06%E
    • Net Assets YoY-64.70%E
  • Cash ScoreD
    • Cash Flow Margin-133.93%D
    • OCF YoY0.59%C
  • Operating ScoreA
    • Turnover0.91A
  • Debt ScoreD
    • Gearing Ratio69.96%D

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Milestone Scientific Inc. Earnings Call Highlights Strategic Gains

    Milestone Scientific Inc. (MLSS) held its Q3 earnings call, highlighting successful cost management and strategic initiatives in the Dental segment. The company secured Medicare payment rates for its CompuFlo system but faces challenges in domestic revenue growth and broader commercial rollout. Operating expenses were reduced by over $0.5 million, and international dental sales increased. Revenues for Q3 and nine months ended September 30, 2025, were $2.4 million and $6.9 million, respectively. The company maintains a positive outlook with a stable financial position and continues to focus on streamlining operations and advancing its reimbursement strategy.

    Tip Ranks·
    US
    MLSS
    +1.37%
    Tip Ranks·
    US
    MLSS
    +1.37%

    Milestone Scientific (MLSS) Stock Jumps Over 35% After Hours — Here's Why

    Milestone Scientific (MLSS) shares surged 35.67% after-hours following its third-quarter results. The company reported reduced operating expenses by over $500,000, leading to a 23% decrease in operating loss to $1.1 million. Net loss narrowed to $1.2 million, or $0.01 per share. Revenue was mixed, with a slight decline in Q3 but a 5% increase for the first nine months. The company is advancing its reimbursement strategy. Despite the recent surge, MLSS shares have fallen 59.61% year-to-date.

    fidelity·
    US
    MLSS
    +1.37%
    fidelity·
    US
    MLSS
    +1.37%

    Milestone Scientific Director Leonard Osser Resigns

    Milestone Scientific Inc. announced the resignation of Leonard A. Osser as director, effective immediately. Osser will continue his involvement with the company through an employment agreement and consulting arrangement with U.S. Asian Consulting Group, LLC.

    Reuters·
    US
    MLSS
    +1.37%
    Reuters·
    US
    MLSS
    +1.37%

    Milestone Scientific shares are trading higher after the company reported better-than-expected Q3 sales results.

    benzinga_article·
    US
    MLSS
    +1.37%
    benzinga_article·
    US
    MLSS
    +1.37%

    Milestone Scientific Q3 revenue dips, net loss narrows

    Milestone Scientific's Q3 revenue decreased slightly due to lower domestic dental sales, but net loss narrowed to $1.2 million from $1.5 million. The company improved operating loss by 23% through cost-reduction initiatives. Milestone expects improved margins and revenue stability from operational transformation and is advancing its reimbursement strategy for broader adoption of CompuFlo®. Analysts rate the stock as a 'buy' with a median 12-month price target of $2.00, significantly above its current price.

    Reuters·
    US
    MLSS
    +1.37%
    Reuters·
    US
    MLSS
    +1.37%
    © 2025 Longbridge｜Disclaimer